Skip to main content

Agitation News (Page 5)

Teen Dating Violence Is Risk Factor for Negative Long-Term Outcomes

THURSDAY, May 4, 2023 – Teen dating violence (TDV) in adolescence is a risk factor for negative long-term outcomes, according to a review published online May 2 in Pediatrics. Antonio Piolanti,...

FDA Approves Igalmi (dexmedetomidine) Sublingual Film for Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I or II Disorder in Adults

NEW HAVEN, Conn., April 06, 2022 (GLOBE NEWSWIRE) – BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence (AI) approaches to identify and develop...

FDA Approves Adasuve (loxapine) Inhalation Powder for the Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I Disorder in Adults

MOUNTAIN VIEW, Calif., Dec. 21, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Adasuve (loxapine) Inhalation Powder 10 mg ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Agitated State

Related drug support groups

citalopram, olanzapine, risperidone